(5-Fluoropyrimidin-2-yl)acetic acid, 95.0%, 250mg

3-Bromo-2-chloroisonicotinic acid, 97%, 1g

5-Bromo-4-chloro-1H-indol-3-yl butyrate, 95.0%, 1g

1,3-Di-tert-butyl-5-methyl-5-nitro-1,3-diazinane, 500mg

5-Bromo-N-(3,5-dimethoxybenzyl)-2,4-difluoro-N-(5-fluorothiazol-2-yl)benzenesulfonamide, 95%, 100mg

3-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)benzene-1-sulfonic acid, 98%, 1g

Óxido de silicio(II) en polvo 99,9% -325 malla 50 g

3'-Methoxy-2,2,2-trifluoroacetophenone, 97.0%, 1g

4-Bromotriphenylamine>97.0%(GC)25g

N-(2-Chlorophenyl)hydrazinecarboxamide, 95+%, 100mg

4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-ylmethanol, 95.0%, 5g

3-Bromo-4-iodothiophene, 95.0%, 5g

3,4-(Methylenedioxy)cinnamic acid, 98.0%, 25g